TPG Group Holdings (SBS) Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,238,533
| Closed | -$23.4M | – | 55 |
|
|
2019
Q3 | $23.4M | Hold |
1,238,533
| – | – | 0.34% | 36 |
|
|
2019
Q2 | $14.6M | Hold |
1,238,533
| – | – | 0.22% | 39 |
|
|
2019
Q1 | $16.9M | Hold |
1,238,533
| – | – | 0.33% | 38 |
|
|
2018
Q4 | $12.7M | Hold |
1,238,533
| – | – | 0.21% | 43 |
|
|
2018
Q3 | $20.6M | Hold |
1,238,533
| – | – | 0.26% | 42 |
|
|
2018
Q2 | $19.6M | Hold |
1,238,533
| – | – | 0.26% | 43 |
|
|
2018
Q1 | $15.7M | Hold |
1,238,533
| – | – | 0.24% | 34 |
|
|
2017
Q4 | $14.2M | Hold |
1,238,533
| – | – | 0.22% | 34 |
|
|
2017
Q3 | $15.2M | Hold |
1,238,533
| – | – | 0.25% | 35 |
|
|
2017
Q2 | $14.2M | Hold |
1,238,533
| – | – | 0.19% | 37 |
|
|
2017
Q1 | $25.8M | Hold |
1,238,533
| – | – | 0.31% | 36 |
|
|
2016
Q4 | $25.8M | Hold |
1,238,533
| – | – | 0.28% | 36 |
|
|
2016
Q3 | $40.6M | Hold |
1,238,533
| – | – | 0.41% | 30 |
|
|
2016
Q2 | $30.9M | Hold |
1,238,533
| – | – | 0.34% | 31 |
|
|
2016
Q1 | $30.3M | Hold |
1,238,533
| – | – | 0.3% | 31 |
|
|
2015
Q4 | $40.9M | Hold |
1,238,533
| – | – | 0.3% | 28 |
|
|
2015
Q3 | $40.6M | Hold |
1,238,533
| – | – | 0.2% | 26 |
|
|
2015
Q2 | $65.6M | Sell |
1,238,533
-1,250,000
| -50% | -$45.5M | 0.3% | 13 |
|
|
2015
Q1 | $71.8M | Hold |
2,488,533
| – | – | 0.36% | 13 |
|
|
2014
Q4 | $72.4M | Hold |
2,488,533
| – | – | 0.44% | 12 |
|
|
2014
Q3 | $31.6M | Hold |
2,488,533
| – | – | 0.21% | 18 |
|
|
2014
Q2 | $49.9M | Buy |
+2,488,533
| New | +$35M | 0.31% | 16 |
|
TPG Group Holdings (SBS) Advisors's ALDR Position: Q4 2019 in Review
TPG Group Holdings (SBS) Advisors sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 1,238,533 shares — an estimated $23.4M sold.
TPG Group Holdings (SBS) Advisors first reported a position in ALDR in Q2 2014 and held it in 22 quarters. The position peaked at $72.4M in Q4 2014. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- TPG Group Holdings (SBS) Advisors reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- TPG Group Holdings (SBS) Advisors sold 1,238,533 Alder Biopharmaceuticals shares in Q4 2019, an estimated $23.4M.
- TPG Group Holdings (SBS) Advisors first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 22 quarters.
- TPG Group Holdings (SBS) Advisors's Alder Biopharmaceuticals position peaked at $72.4M in Q4 2014.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.